Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Oxycodone hydrochloride
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Reltebon 60mg modified-release tablets
0407020ADBKAHAQ
|
Reltebon | Oxycodone hydrochloride | Central Nervous System | 242 |
|
Reltebon 80mg modified-release tablets
0407020ADBKAEAI
|
Reltebon | Oxycodone hydrochloride | Central Nervous System | 199 |
|
Oxycodone 20mg tablets
0407020ADAAAVAV
|
Oxycodone hydrochloride | Oxycodone hydrochloride | Central Nervous System | 194 |
|
Oxyact 10mg tablets
0407020ADBUAAAU
|
Oxyact | Oxycodone hydrochloride | Central Nervous System | 191 |
|
Oxycodone 120mg modified-release tablets
0407020ADAAAPAP
|
Oxycodone hydrochloride | Oxycodone hydrochloride | Central Nervous System | 176 |
|
Shortec 10mg/ml concentrate oral solution
0407020ADBJAHAB
|
Shortec | Oxycodone hydrochloride | Central Nervous System | 159 |
|
Renocontin 5mg modified-release tablets
0407020ADBRAAAK
|
Renocontin | Oxycodone hydrochloride | Central Nervous System | 155 |
|
OxyNorm 10mg/1ml solution for injection ampoules
0407020ADBBAFAL
|
OxyNorm | Oxycodone hydrochloride | Central Nervous System | 154 |
|
Renocontin 40mg modified-release tablets
0407020ADBRAFAH
|
Renocontin | Oxycodone hydrochloride | Central Nervous System | 129 |
|
Renocontin 30mg modified-release tablets
0407020ADBRAEAR
|
Renocontin | Oxycodone hydrochloride | Central Nervous System | 127 |
|
Abtard 40mg modified-release tablets
0407020ADBMAEAH
|
Abtard | Oxycodone hydrochloride | Central Nervous System | 125 |
|
Oxylan 40mg prolonged-release tablets (G.L. Pharma UK Ltd)
0407020ADBFADAH
|
Oxylan | Oxycodone hydrochloride | Central Nervous System | 122 |
|
Oxycodone 5mg/5ml oral solution
0407020ADAAAJAJ
|
Oxycodone hydrochloride | Oxycodone hydrochloride | Central Nervous System | 101 |
|
Renocontin 15mg modified-release tablets
0407020ADBRACAS
|
Renocontin | Oxycodone hydrochloride | Central Nervous System | 87 |
|
Oxylan 30mg prolonged-release tablets (G.L. Pharma UK Ltd)
0407020ADBFALAR
|
Oxylan | Oxycodone hydrochloride | Central Nervous System | 78 |
|
Shortec 10mg/1ml solution for injection ampoules
0407020ADBJADAL
|
Shortec | Oxycodone hydrochloride | Central Nervous System | 77 |
|
Abtard 30mg modified-release tablets
0407020ADBMAFAR
|
Abtard | Oxycodone hydrochloride | Central Nervous System | 73 |
|
Oxyact 20mg tablets
0407020ADBUABAV
|
Oxyact | Oxycodone hydrochloride | Central Nervous System | 65 |
|
Abtard 60mg modified-release tablets
0407020ADBMAGAQ
|
Abtard | Oxycodone hydrochloride | Central Nervous System | 64 |
|
Oxylan 15mg prolonged-release tablets (G.L. Pharma UK Ltd)
0407020ADBFAKAS
|
Oxylan | Oxycodone hydrochloride | Central Nervous System | 54 |
|
OxyContin 120mg modified-release tablets
0407020ADBCAFAP
|
OxyContin | Oxycodone hydrochloride | Central Nervous System | 50 |
|
Abtard 10mg modified-release tablets
0407020ADBMABAF
|
Abtard | Oxycodone hydrochloride | Central Nervous System | 47 |
|
Renocontin 60mg modified-release tablets
0407020ADBRAGAQ
|
Renocontin | Oxycodone hydrochloride | Central Nervous System | 46 |
|
Ixyldone 10mg modified-release tablets
0407020ADBTABAF
|
Ixyldone | Oxycodone hydrochloride | Central Nervous System | 36 |
|
Oxylan 80mg prolonged-release tablets (G.L. Pharma UK Ltd)
0407020ADBFAEAI
|
Oxylan | Oxycodone hydrochloride | Central Nervous System | 36 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.